Study identifier:D9603C00001
ClinicalTrials.gov identifier:NCT05454787
EudraCT identifier:N/A
CTIS identifier:N/A
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All case investigation)
life threatening bleeding
N/A
No
-
All
300
Observational
n/a - n/a
Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Sept 2024 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|